125.90
price up icon1.40%   1.74
after-market アフターアワーズ: 125.90
loading

Glaukos Corporation (GKOS) 最新ニュース

pulisher
Jan 22, 2026

Why (GKOS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Jan 22, 2026
pulisher
Jan 22, 2026

Why Analysts See The Glaukos (GKOS) Story Shifting After The Latest Price Target Change - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

GKOS: Stifel Boosts Glaukos Price Target to $160 with Buy Rating | GKOS Stock News - GuruFocus

Jan 22, 2026
pulisher
Jan 22, 2026

Stifel Nicolaus Issues Positive Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Glaukos stock price target raised to $160 from $115 at Stifel on Epioxa outlook - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

What makes Glaukos (GKOS) a good investment? - MSN

Jan 22, 2026
pulisher
Jan 22, 2026

What Makes Glaukos (GKOS) a Good Investment? - Insider Monkey

Jan 22, 2026
pulisher
Jan 21, 2026

Glaukos Advances Phase 3 Glaucoma Implant Trial, Keeping GKOS in Focus for Investors - TipRanks

Jan 21, 2026
pulisher
Jan 21, 2026

Tuesday Insider Activity: Top Execs Make Moves at Reddit, Glaukos By Investing.com - Investing.com Nigeria

Jan 21, 2026
pulisher
Jan 21, 2026

Tuesday Insider Activity: Top Execs Make Moves at Reddit, Glaukos - Investing.com

Jan 21, 2026
pulisher
Jan 21, 2026

Aug Macro: Is Glaukos Corporation affected by consumer sentimentTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 20, 2026

Glaukos (NYSE:GKOS) CEO Sells $10,126,325.00 in Stock - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Glaukos (NYSE:GKOS) CEO Thomas William Burns Sells 186,945 Shares - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Burns, Glaukos chairman & ceo, sells $31.6 million in GKOS stock - Investing.com UK

Jan 20, 2026
pulisher
Jan 20, 2026

Burns, Glaukos chairman & ceo, sells $31.6 million in GKOS stock By Investing.com - Investing.com South Africa

Jan 20, 2026
pulisher
Jan 20, 2026

Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 - Business Wire

Jan 20, 2026
pulisher
Jan 18, 2026

How Glaukos Corporation stock performs in rate cut cyclesMarket Risk Summary & Low Volatility Stock Suggestions - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 17, 2026

EPS Watch: What hedge funds are buying ProShares Trust ProShares UltraShort FTSE China 50Share Buyback & Trade Opportunity Analysis - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Glaukos Sees Revenue Surge as Analysts Raise Price Targets - StocksToTrade

Jan 16, 2026
pulisher
Jan 16, 2026

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS) - The Globe and Mail

Jan 16, 2026
pulisher
Jan 16, 2026

How Glaukos’ Reaffirmed 2026 Sales Guidance and iDose TR Momentum Will Impact Glaukos (GKOS) Investors - simplywall.st

Jan 16, 2026
pulisher
Jan 15, 2026

Glaukos (NYSE:GKOS) Trading 7.8% HigherHere's What Happened - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

Glaukos Surges with Strong Year-End Financials and Optimistic Future Outlook - StocksToTrade

Jan 15, 2026
pulisher
Jan 15, 2026

Glaukos Reports Preliminary Q4 and 2025 Results, Reaffirms 2026 Revenue Guidance - VisionMonday.com

Jan 15, 2026
pulisher
Jan 14, 2026

Needham Reiterates Buy Rating for Glaukos (GKOS) | GKOS Stock Ne - GuruFocus

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy By Investing.com - Investing.com Australia

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy - Investing.com Canada

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos (GKOS) Shares Drop Significantly in Recent Trading - GuruFocus

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results - Investing.com Australia

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos' (GKOS) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results By Investing.com - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jan 14, 2026
pulisher
Jan 14, 2026

S&P 500 Futures Fall in Premarket Trading; Glaukos, Fortinet Lag - Barron's

Jan 14, 2026
pulisher
Jan 14, 2026

What 14 Analyst Ratings Have To Say About Glaukos - Benzinga

Jan 14, 2026
pulisher
Jan 14, 2026

Breakout Move: What is the long term forecast for Glaukos Corporation stockPortfolio Performance Report & Consistent Profit Trade Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance By Investing.com - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 13, 2026

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2 - PharmiWeb.com

Jan 13, 2026
pulisher
Jan 13, 2026

Glimpse Into Glaukos (GKOS): Financial Standing and Cash Reserves - GuruFocus

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos Reports Strong Preliminary Q4 and 2025 Sales Growth - TipRanks

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos (GKOS) Reaffirms 2026 Revenue Forecast at $600M-$620M - GuruFocus

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos (GKOS) Projects Strong Q4 Glaucoma Sales Performance - GuruFocus

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos stock falls after preliminary Q4 sales beat estimates By Investing.com - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance - Investing.com

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos Reaffirms 2026 Revenue Guidance of $600 Million to $620 Million, Shares Fall After Hours - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos stock falls after preliminary Q4 sales beat estimates - Investing.com UK

Jan 13, 2026
pulisher
Jan 13, 2026

Glaukos announces preliminary, unaudited fourth quarter results - marketscreener.com

Jan 13, 2026
$280.00
price down icon 1.74%
medical_devices STE
$260.90
price down icon 0.11%
medical_devices PHG
$29.74
price up icon 1.81%
$73.92
price up icon 2.51%
$81.89
price up icon 0.97%
medical_devices EW
$84.44
price down icon 0.82%
大文字化:     |  ボリューム (24 時間):